Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Paratek Pharmaceuticals Inc (PRTK)  
$2.23 0.00 (0.00%) as of 4:30 Wed 9/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 45,640,000
Market Cap: 101.78(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.52 - $2.8
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for diseases or other public health threats for civilian, government and military use. Co.'s U.S. Food and Drug Administration approved commercial product, NUZYRA®, is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections caused by susceptible pathogens. SEYSARA®, is being marketed by Almirall, LLC in the U.S. as a new once-daily oral therapy for the treatment of moderate to severe acne vulgaris.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 788,500
Total Buy Value $0 $0 $0 $1,282,057
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 5
Total Shares Sold 0 0 142,346 584,838
Total Sell Value $0 $0 $313,161 $1,304,750
Total People Sold 0 0 4 7
Total Sell Transactions 0 0 4 30
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 571
  Page 1 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Stein Jeffrey Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (68,625) 0     -
   Radie Robert S Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (73,000) 0     -
   Bigham Michael Exec. Chairman of the Board   •       •      –    2023-09-21 4 D $0.00 $0 D/D (1,358,032) 0     -
   Loh Evan CEO   •       •      –    2023-09-21 4 D $0.00 $0 D/D (1,327,981) 0     -
   Haskel William M. CLO, General Counsel & Sec.   •       –      –    2023-09-21 4 D $0.00 $0 D/D (447,024) 0     -
   Woodrow Adam President & Chief Commercial   •       –      –    2023-09-21 4 D $0.00 $0 D/D (749,034) 0     -
   Hoffmann Rolf K Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (84,000) 0     -
   Brenner Randall B. Chief Development & Regulatory   •       –      –    2023-09-21 4 D $0.00 $0 D/D (415,209) 0     -
   Peterson Kristine Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (79,000) 0     -
   Baylor-Henry Minnie Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (59,200) 0     -
   Franson Timothy R Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (72,000) 0     -
   Dietz Thomas John Director   –       •      –    2023-09-21 4 D $0.00 $0 D/D (69,250) 0     -
   Haskel William M. CLO, General Counsel & Sec.   •       –      –    2023-08-09 4 AS $2.20 $75,957 D/D (34,526) 447,024 2%     
   Bigham Michael Exec. Chairman of the Board   •       •      –    2023-08-09 4 AS $2.20 $68,750 D/D (31,250) 1,334,702 2%     
   Brenner Randall B. Chief Development & Regulatory   •       –      –    2023-08-09 4 AS $2.20 $60,727 D/D (27,603) 415,209 2%     
   Loh Evan CEO   •       •      –    2023-08-09 4 S $2.20 $107,727 D/D (48,967) 1,327,981 -2%     
   Woodrow Adam President & Chief Commercial   •       –      –    2023-08-08 4 A $0.00 $0 D/D 98,750 750,034     -
   Haskel William M. CLO, General Counsel & Sec.   •       –      –    2023-08-08 4 A $0.00 $0 D/D 73,750 481,550     -
   Bigham Michael Exec. Chairman of the Board   •       •      –    2023-08-08 4 A $0.00 $0 D/D 156,250 1,365,952     -
   Brenner Randall B. Chief Development & Regulatory   •       –      –    2023-08-08 4 A $0.00 $0 D/D 67,500 442,812     -
   Loh Evan CEO   •       •      –    2023-08-08 4 A $0.00 $0 D/D 168,750 1,376,948     -
   Dondero James D 10% Owner   •       •       •   2023-03-23 4 B $1.73 $173,000 I/I 100,000 2,156,000 1.5 31%     
   Dondero James D 10% Owner   •       •       •   2023-03-22 4 B $1.77 $187,620 I/I 106,000 2,056,000 1.5 22%     
   Dondero James D 10% Owner   •       •       •   2023-03-21 4 B $1.74 $421,950 I/I 242,500 1,307,617 1.5 18%     
   Dondero James D 10% Owner   •       •       •   2023-03-20 4 B $1.40 $147,192 I/I 105,137 2,239,770 1.5 59%     

  571 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed